144 related articles for article (PubMed ID: 8266769)
1. Octreotide and postoperative enterocutaneous fistulae: a controlled prospective study.
Scott NA; Finnegan S; Irving MH
Acta Gastroenterol Belg; 1993; 56(3-4):266-70. PubMed ID: 8266769
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas.
Alivizatos V; Felekis D; Zorbalas A
Hepatogastroenterology; 2002; 49(46):1010-2. PubMed ID: 12143189
[TBL] [Abstract][Full Text] [Related]
3. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula.
Sancho JJ; di Costanzo J; Nubiola P; Larrad A; Beguiristain A; Roqueta F; Franch G; Oliva A; Gubern JM; Sitges-Serra A
Br J Surg; 1995 May; 82(5):638-41. PubMed ID: 7613936
[TBL] [Abstract][Full Text] [Related]
4. [Value of octreotide in the treatment of postoperative enterocutaneous fistula].
Sleth JC; Andraos Y; Borie F; Dumay R; Legroux P
Ann Fr Anesth Reanim; 1994; 13(5):738-40. PubMed ID: 7733526
[TBL] [Abstract][Full Text] [Related]
5. Octreotide and gastrointestinal fistulae.
Scott NA; Finnegan S; Irving MH
Digestion; 1990; 45 Suppl 1():66-70; discussion 70-1. PubMed ID: 2185968
[TBL] [Abstract][Full Text] [Related]
6. Complicated enterocutaneous fistulas: failure of octreotide to improve healing.
Alvarez C; McFadden DW; Reber HA
World J Surg; 2000 May; 24(5):533-7; discussion 538. PubMed ID: 10787072
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of enterocutaneous fistula with or without octreotide and parenteral nutrition].
Hernández-Aranda JC; Gallo-Chico B; Flores-Ramírez LA; Avalos-Huante R; Magos-Vázquez FJ; Ramírez-Barba EJ
Nutr Hosp; 1996; 11(4):226-9. PubMed ID: 8962902
[TBL] [Abstract][Full Text] [Related]
8. Randomized, placebo-controlled, double-blind study of the efficacy of lanreotide 30 mg PR in the treatment of pancreatic and enterocutaneous fistulae.
Gayral F; Campion JP; Regimbeau JM; Blumberg J; Maisonobe P; Topart P; Wind P;
Ann Surg; 2009 Dec; 250(6):872-7. PubMed ID: 19953707
[TBL] [Abstract][Full Text] [Related]
9. Treatment of external biliary, pancreatic and intestinal fistulas with a somatostatin analog.
Kocak S; Bumin C; Karayalcin K; Alacayir I; Aribal D
Dig Dis; 1994; 12(1):62-8. PubMed ID: 8200125
[TBL] [Abstract][Full Text] [Related]
10. Treatment of gastrointestinal fistulas with Sandostatin.
Sitges-Serra A; Guirao X; Pereira JA; Nubiola P
Digestion; 1993; 54 Suppl 1():38-40. PubMed ID: 8359567
[TBL] [Abstract][Full Text] [Related]
11. Octreotide in the management of postoperative enterocutaneous fistulas and stress ulcer bleeding.
Chen RJ; Fang JF; Chen MF
Am J Gastroenterol; 1992 Sep; 87(9):1212-5. PubMed ID: 1519586
[TBL] [Abstract][Full Text] [Related]
12. Role of somatostatin analogues in the management of enterocutaneous fistulae.
Jamil M; Ahmed U; Sobia H
J Coll Physicians Surg Pak; 2004 Apr; 14(4):237-40. PubMed ID: 15228830
[TBL] [Abstract][Full Text] [Related]
13. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?
Martineau P; Shwed JA; Denis R
Am J Surg; 1996 Oct; 172(4):386-95. PubMed ID: 8873537
[TBL] [Abstract][Full Text] [Related]
14. Causes and management of postoperative enterocutaneous fistulas.
Memon AS; Siddiqui FG
J Coll Physicians Surg Pak; 2004 Jan; 14(1):25-8. PubMed ID: 14764257
[TBL] [Abstract][Full Text] [Related]
15. Octreotide for enterocutaneous fistulas of Crohn's disease.
Lavy A; Yasin K
Can J Gastroenterol; 2003 Sep; 17(9):555-8. PubMed ID: 14532930
[TBL] [Abstract][Full Text] [Related]
16. Octreotide for treatment of postoperative alimentary tract fistulas.
Paran H; Neufeld D; Kaplan O; Klausner J; Freund U
World J Surg; 1995; 19(3):430-3; discussion 433-4. PubMed ID: 7639001
[TBL] [Abstract][Full Text] [Related]
17. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995.
Nubiola P; Badia JM; Martinez-Rodenas F; Gil MJ; Segura M; Sancho J; Sitges-Serra A
Ann Surg; 1989 Jul; 210(1):56-8. PubMed ID: 2500900
[TBL] [Abstract][Full Text] [Related]
18. Treatment of high output enterocutaneous fistulas with a somatostatin analogue and famotidine.
Kusunoki M; Shoji Y; Okamoto T; Kusuhara K; Sakanoue Y; Utsunomiya J
Eur J Surg; 1992 Aug; 158(8):443-5. PubMed ID: 1356486
[No Abstract] [Full Text] [Related]
19. Enterocutaneous fistula: are treatments improving?
Draus JM; Huss SA; Harty NJ; Cheadle WG; Larson GM
Surgery; 2006 Oct; 140(4):570-6; discussion 576-8. PubMed ID: 17011904
[TBL] [Abstract][Full Text] [Related]
20. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula.
Jenkins SA; Javle P; Parsons KF; Balan KK; Berein A
Br J Surg; 1995 Nov; 82(11):1576. PubMed ID: 8535820
[No Abstract] [Full Text] [Related]
[Next] [New Search]
